# The Influence of Gene Polymorphism on Clinical Outcomes in Patients Undergoing PCI

> **NCT03758248** · — · UNKNOWN · sponsor: **Beijing Anzhen Hospital** · enrollment: 12000 (estimated)

## Conditions studied

- Antiplatelet Therapy
- CYP2C19 Polymorphism

## Interventions

- **GENETIC:** CYP2C19

## Key facts

- **NCT ID:** NCT03758248
- **Lead sponsor:** Beijing Anzhen Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-12-01
- **Primary completion:** 2021-08-31
- **Final completion:** 2021-09-30
- **Target enrollment:** 12000 (ESTIMATED)
- **Last updated:** 2020-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03758248

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03758248, "The Influence of Gene Polymorphism on Clinical Outcomes in Patients Undergoing PCI". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03758248. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*